SwePub
Sök i SwePub databas

  form:Ext_t

Träfflista för sökning "L773:1879 1913 OR L773:0002 9149 "

form:Search_simp_t: L773:1879 1913 OR L773:0002 9149

  • navigation:Result_t 1-10 navigation:of_t 299
hitlist:Modify_result_t
   
hitlist:Enumeration_thitlist:Reference_thitlist:Reference_picture_thitlist:Find_Mark_t
1.
  •  
2.
  • Albertsson, Per, 1956, et al. (creator_code:aut_t)
  • Morbidity and use of medical resources in patients with chest pain and normal or near-normal coronary arteries.
  • 1997
  • record:In_t: The American journal of cardiology. - : Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 79:3, s. 299-304
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • To evaluate morbidity and use of medical resources in patients with chest pain and normal or near-normal coronary angiograms: 2,639 consecutive patients who underwent coronary angiograms due to chest pain were registered. Two years thereafter all patients who showed normal or near-normal coronary angiograms were approached with a questionnaire regarding hospitalization during the last 4 years (2 years before and 2 years after angiography). All medical files were also examined. Of the patients who underwent angiography, 163 (6%) had no significant stenoses, and of these, 113 showed complete normal angiograms and 50 showed mild (i.e. <50%) stenoses. During the 2 years before diagnostic angiogram, 66% of the patients were hospitalized compared with only 35% during 2 years after angiography (p <0.001). The reduction in hospitalization was due to curtailed utilization of medical resources for cardiac reasons; mean days in hospital was 6.6 days before angiography versus 2.8 days after (p <0.001). There were no significant differences in hospitalization when comparing patients with mild stenoses and completely normal angiograms. There were, furthermore, no differences between patients with positive or negative exercise tests. Thus, the need for hospitalization is significantly reduced after a diagnostic angiogram reveals normal or near-normal coronary arteries.
  •  
3.
  •  
4.
  •  
5.
  • Engdahl, J, et al. (creator_code:aut_t)
  • Can we define patients with no and those with some chance of survival when found in asystole out of hospital?
  • 2000
  • record:In_t: American Journal of Cardiology. - : Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 86:6, s. 610-614
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • We describe the epidemiology, prognosis, and circumstances at resuscitation among a consecutive population of patients with out-of-hospital cardiac arrest (OHCA) with asystole as the arrhythmia first recorded by the Emergency Medical Service (EMS), and identify factors associated with survival. We included all patients in the municipality of Göteborg, regardless of age and etiology, who experienced an OHCA between 1981 and 1997. There were a total of 4,662 cardiac arrests attended by the EMS during the study period. Of these, 1,635 (35%) were judged as having asystole as the first-recorded arrhythmia: 156 of these patients (10%) were admitted alive to hospital, and 32 (2%) were discharged alive. Survivors were younger (median age 58 vs 68 years) and had a witnessed cardiac arrest more often than nonsurvivors (78% vs 50%). Survivors also had shorter intervals from collapse to arrival of ambulance (3.5 vs 6 minutes) and the mobile coronary care unit (MCCU) (5 vs 10 min), and they received atropine less often on scene. There were also a greater proportion of survivors with noncardiac etiologies of cardiac arrest (48% vs 27%). Survivors to discharge also displayed higher degrees of consciousness on arrival to the emergency department in comparison to nonsurvivors. Multivariate analysis among all patients with asystole indicated age (p = 0.01) and witnessed arrest (p = 0.03) as independent predictors of an increased chance of survival. Multivariate analysis among witnessed arrests indicated short time to arrival of the MCCU (p < 0.001) and no treatment with atropine (p = 0.05) as independent predictors of survival. Fifty-five percent of patients discharged alive had none or small neurologic deficits (cerebral performance categories 1 or 2). No patients > 70 years old with unwitnessed arrests (n = 211) survived to discharge.
  •  
6.
  • Henriksen, Egil, et al. (creator_code:aut_t)
  • An echocardiographic study comparing male Swedish elite orienteers with other elite endurance athletes
  • 1997
  • record:In_t: American Journal of Cardiology. - 0002-9149 .- 1879-1913. ; 79:4, s. 521-524
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Between 1979 and 1992, there were 16 known cases of sudden unexpected cardiac death among young Swedish orienteers, whose autopsies showed myocarditis to be a common finding. Therefore, 96 elite orienteers and 47 controls underwent echocardiography, showing left ventricular wall motion abnormalities in 9% of the orienteers compared with 4% in the controls.
  •  
7.
  • Herlitz, Johan (creator_code:aut_t)
  • Comparison of lisinopril versus digoxin for congestive heart failure during maintenance diuretic therapy
  • 1992
  • record:In_t: American Journal of Cardiology. - : Elsevier Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 70:10, s. 84-90
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • Lisinopril 5–20 mg once daily was compared with digoxin 0.125–0.375 mg once daily in a double-blind, randomized, parallel-group study involving 217 patients with mild-to-moderate heart failure (New York Heart Association [NYHA] grades II–III) who were maintained on optimized diuretic therapy. After 6 weeks of treatment, digoxin and lisinopril had increased exercise duration by 18 seconds (p = 0.015) and 32 seconds (p = 0.0007), respectively, versus the baseline run-in period. The difference between treatments was not statistically significant (p = 0.1343). After 12 weeks, digoxin and lisinopril had increased exercise duration by 29 seconds and 51 seconds, respectively. The effect of digoxin compared with the baseline value was not significant but that for lisinopril was (p = 0.0027). The difference between treatments approached statistical significance (p = 0.0813). There was no difference between lisinopril and digoxin with regard to their effects on the frequency of ventricular ectopic counts, couplets, or nonsustained ventricular tachycardia. Blood pressures were not significantly different between treatments, although both systolic and diastolic blood pressure were consistently lower in the lisinopril group throughout randomized treatment. The proportions of patients demonstrating an improvement in NYHA grading were similar for both lisinopril and digoxin. Both treatments had similar effects on the symptoms of heart failure. Both drugs appeared to be equally well tolerated with a similar frequency of adverse events reported for both drugs (30% for lisinopril vs 29% for digoxin). Withdrawals from treatment were of a similar frequency for both treatments. It is concluded that lisinopril may be a useful alternative to digitalis in patients with heart failure who remain symptomatic on diuretic therapy.
  •  
8.
  • Herlitz, Johan, et al. (creator_code:aut_t)
  • Effect of media campaign on delay times and ambulance use in suspected acut myocardial infarction
  • 1989
  • record:In_t: American Journal of Cardiology. - : Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 64:1, s. 90-93
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • The early phase in suspected acute myocardial infarction (AMI) is particularly critical. More than 50% of deaths from coronary artery disease occur outside the hospital mainly due to ventricular fibrillation.1 Recent experiences strongly indicate that early intervention with thrombolysis2–4 and β blockers5,6 can limit myocardial damage and thereby improve prognosis. Delay times in suspected AMI have remained stable over the years. Therefore, a media campaign was started in the urban area of Göteborg, Sweden, with the intention to shorten delay times and to increase ambulance use in patients with suspected AMI.
  •  
9.
  • Herlitz, Johan, et al. (creator_code:aut_t)
  • Effect of metoprolol on indirect signs of the size and severity of acute myocardial infarction
  • 1983
  • record:In_t: American Journal of Cardiology. - : Elsevier Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 51:8, s. 1282-1288
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • In a double-blind randomized trial, 1,395 patients with suspected acute myocardial infarction (MI) were investigated to evaluate the possibility of limiting indirect signs of the size and severity of acute MI with the beta1-selective adrenoceptor antagonist metoprolol. Metoprolol (15 mg) was given intravenously and followed by oral administration for 3 months (200 mg daily). Placebo was given in the same way. The size of the MI was estimated by heat-stable lactate dehydrogenase (LD[EC 1.1.1.27]) analyses and precordial electrocardiographic mapping. Lower maximal enzyme activities compared with placebo were seen in the metoprolol group (11.1 ± 0.5 μkat · liter−1)when the patient was treated within 12 hours of the onset of pain (13.3 ± 0.6 μkat · liter−1; n = 936; p = 0.009). When treatment was started later than 12 hours, no difference was found between the 2 groups. Enzyme analyses were performed in all but 20 patients (n = 1,375). Precordial mapping with 24 chest electrodes was performed in patients with anterior wall MI. The final total R-wave amplitude was higher and the final total Q-wave amplitude lower in the metoprolol group than in the placebo group. Patients treated with metoprolol ≤12 hours also showed a decreased need for furosemide, a shortened hospital stay, and a significantly reduced 1-year mortality compared with the placebo group, whereas no difference was observed among patients treated later on. After 3 months, however, there was a similar reduction in mortality among patients in whom therapy was started 12 hours and >12 hours after the onset of pain. The results support the hypothesis that intravenous metoprolol followed by oral treatment early in the course of suspected myocardial infarction can limit infarct size and improve longterm prognosis.
  •  
10.
  • Herlitz, Johan (creator_code:aut_t)
  • Metoprolol in acute myocardial infarction. Enzymatic estimation of infarct size. The MIAMI Trial Research Group
  • 1985
  • record:In_t: American Journal of Cardiology. - : Elsevier Excerpta Medica, Inc.. - 0002-9149 .- 1879-1913. ; 56:14, s. 27-29
  • swepub:Mat_article_t (swepub:level_refereed_t)abstract
    • The maximum serum activity for aspartate aminotransferase (s-ASAT) during the first 3 days was recorded in 5,507 patients with suspected or definite acute myocardial infarction. The s-ASAT activity was corrected for the normal range from each center. The median s-ASAT activity was 4.9 arbitrary units in the placebo group versus 4.6 arbitrary units in the metoprolol group (p = 0.072). Univariate analyses indicated that the delay time between onset of symptoms and randomization and sympathetic activity at entry significantly influenced the effect of metoprolol. A similar decrease in serum enzyme activity after metoprolol treatment was observed independent of signs of infarct localization on the entry electrocardiogram.
  •  
Skapa referenser, mejla, bekava och länka
  • navigation:Result_t 1-10 navigation:of_t 299
swepub:Mat_t
swepub:mat_article_t (285)
swepub:mat_conferencepaper_t (11)
swepub:mat_researchreview_t (2)
swepub:mat_publicationother_t (1)
swepub:Level_t
swepub:level_refereed_t (286)
swepub:level_scientificother_t (13)
swepub:Hitlist_author_t
Herlitz, Johan (26)
Boman, Kurt (12)
Swedberg, Karl, 1944 (11)
Wallentin, Lars, 194 ... (11)
Rydén, L. (10)
Linde, C (10)
deldatabas:search_more_t
Swedberg, K (9)
Lund, LH (8)
Sylven, C (8)
Erlinge, David (8)
Olsson, Anders (8)
Wallentin, Lars (8)
Holmberg, S. (8)
Braunschweig, F (7)
Holme, Ingar (6)
Zannad, F (6)
Holzmann, MJ (6)
Tornvall, P (6)
Gheorghiade, M. (6)
Gadler, F (6)
Dellborg, Mikael, 19 ... (5)
Butler, J (5)
Platonov, Pyotr G (5)
Maggioni, A. P. (5)
Rosenqvist, M (5)
Lagerqvist, Bo (5)
Armstrong, Paul W. (5)
Eriksson, MJ (5)
Konstam, M. A. (5)
Bergfeldt, L (4)
Herlitz, Johan, 1949 (4)
Komajda, M. (4)
Harrington, Robert A (4)
Moons, Philip, 1968 (4)
Karlsson, Thomas, 19 ... (4)
Hamsten, A (4)
Arheden, Håkan (4)
Pahlm, Olle (4)
Al-Khalili, F (4)
Sartipy, U (4)
Van de Werf, Frans (4)
Schenck-Gustafsson, ... (4)
Lindahl, Bertil, 195 ... (4)
Jernberg, Tomas (4)
Alam, M (4)
Venge, Per (4)
Dalen, M. (4)
Mahaffey, Kenneth W. (4)
Mentz, R. J. (4)
Vaduganathan, M. (4)
deldatabas:search_less_t
swepub:Hitlist_uni_t
swepub_uni:ki_t (107)
swepub_uni:gu_t (49)
swepub_uni:lu_t (49)
swepub_uni:uu_t (40)
swepub_uni:liu_t (33)
swepub_uni:hb_t (29)
deldatabas:search_more_t
swepub_uni:umu_t (24)
swepub_uni:oru_t (4)
swepub_uni:hv_t (3)
swepub_uni:hj_t (3)
swepub_uni:kth_t (1)
swepub_uni:su_t (1)
swepub_uni:mdh_t (1)
swepub_uni:miun_t (1)
swepub_uni:gih_t (1)
swepub_uni:du_t (1)
deldatabas:search_less_t
hitlist:Language_t
language:Eng_t (299)
hitlist:HSV_t
hsv:Cat_3_t (125)
hsv:Cat_2_t (2)
hsv:Cat_5_t (2)
hsv:Cat_1_t (1)
hsv:Cat_4_t (1)
hsv:Cat_6_t (1)

hitlist:Year_t

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt tools:Close_t

tools:Permalink_label_t